Lumasiran
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
Diastereomer separation of phosphorothioate oligonucleotides via conformationally stabilizing ion pairs in reversed-phase liquid chromatography.
Journal: Journal of chromatography. A
Published: April 04, 2026
Bilateral staghorn calculi in primary hyperoxaluria type 1.
Journal: Kidney international
Published: January 15, 2026
A computational model-powered platform to inform the development of GalNAc-conjugated siRNA therapeutics.
Journal: Molecular therapy. Nucleic acids
Published: December 19, 2025
The oxalobiome: unraveling the role of gut microbiota in oxalate metabolism and its implications for kidney health and disease management.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: December 17, 2025
The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1.
Journal: Journal of personalized medicine
Published: November 24, 2025
Class-Specific Adverse Events of Patients Treated with Small Interfering RNA Therapeutics: A Disproportionality Analysis of the United States Food and Drug Administration Adverse Event Reporting System Database Based on the MY FAERS Platform.
Journal: Nucleic acid therapeutics
Published: November 22, 2025
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Journal: Frontiers in pharmacology
Published: October 07, 2025
A Case of Successful Kidney Transplant-Alone in Primary Hyperoxaluria Type 1 Using Lumasiran.
Journal: Clinical transplantation
Published: September 23, 2025
Isolated Kidney Transplant in Primary Hyperoxaluria-1 Enabled by Small Interfering RNA (siRNA) Therapy. Is It Time for Change? Case Report and Review of the Literature.
Journal: Pediatric transplantation
Published: September 11, 2025
Primary hyperoxaluria(s): from trials to real-life data and pipeline therapies.
Journal: Kidney international
Published: July 29, 2025
Administration of lumasiran in a child with infantile oxalosis undergoing chronic peritoneal dialysis: A case report
Journal: Nephrologie & therapeutique
Published: June 11, 2025
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 14, 2025
Last Updated: 06/30/2026